GCEYX
Price
$19.05
Change
+$0.04 (+0.21%)
Updated
Jul 8 closing price
Net Assets
2.85B
RWIFX
Price
$71.16
Change
+$0.03 (+0.04%)
Updated
Jul 8 closing price
Net Assets
135.06B
Interact to see
Advertisement

GCEYX vs RWIFX

Header iconGCEYX vs RWIFX Comparison
Open Charts GCEYX vs RWIFXBanner chart's image
AB Global Core Equity Advisor
Price$19.05
Change+$0.04 (+0.21%)
VolumeN/A
Net Assets2.85B
American Funds Capital World Gr&Inc R5
Price$71.16
Change+$0.03 (+0.04%)
VolumeN/A
Net Assets135.06B
GCEYX vs RWIFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCEYX vs. RWIFX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCEYX is a StrongBuy and RWIFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIFX has more cash in the bank: 135B vs. GCEYX (2.85B). RWIFX pays higher dividends than GCEYX: RWIFX (1.72) vs GCEYX (0.96). GCEYX was incepted earlier than RWIFX: GCEYX (11 years) vs RWIFX (23 years). GCEYX (0.78) is less costly to investors than RWIFX (0.46). GCEYX is a more actively managed with annual turnover of: 52.00 vs. RWIFX (27.00). GCEYX has a lower initial minimum investment than RWIFX: GCEYX (0) vs RWIFX (250). GCEYX annual gain was more profitable for investors over the last year : 12.85 vs. RWIFX (8.23). RWIFX (51.78) and GCEYX (50.14) have equivalent 5 years return.
GCEYXRWIFXGCEYX / RWIFX
Total Expense Ratio0.780.46170%
Annual Report Gross Expense Ratio0.780.46170%
Fund Existence11 years23 years-
Gain YTD12.88613.02299%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.85B135B2%
Annual Yield % from dividends0.961.7256%
Returns for 1 year12.858.23156%
Returns for 3 years40.6449.6282%
Returns for 5 years50.1451.7897%
Returns for 10 years96.1862.09155%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNAZ9.251.20
+14.91%
TransCode Therapeutics Inc
ARVN8.020.23
+2.95%
Arvinas
SPB56.441.50
+2.73%
Spectrum Brands Holdings
LW52.341.37
+2.69%
Lamb Weston Holdings
ATOS0.85N/A
+0.17%
Atossa Therapeutics